Modern Advances in Glucose Monitoring

Slides:



Advertisements
Similar presentations
Self-Management Education Chapter 7 Helen Jones, Lori D Berard, Gail MacNeill, Dana Whitham, Catherine Yu Canadian Diabetes Association 2013 Clinical Practice.
Advertisements

Learning Objectives Participants will be able to understand: Why the Diabetes Medical Management Plan is important What other kinds of plans are most often.
A Day in the Life of a Type 2 Diabetic
Closed-Loop Insulin Delivery in Children
Achieving Glycemic Control in the Hospital Setting Part 4 of 4.
1 Module 7 Discharge Planning Managing the Transition from Inpatient to Outpatient Care Diabetes Special Interest Group Georgia Hospital Association.
Dr Stanley Ngare.  Pharmacology of Types of insulin available  Various routes of delivery & factors that affect absorption  Patient and provider barriers.
October 22, 2012 GHA- Glycemic Management Collaborative.
An Educational Service from GlycoMark
Pattern Recognition Ver D/sv/ What Is Pattern Management ? A systematic approach to making effective use of SMBG data. – Establishing pre-
Dr Zaranyika MBChB(Hons) UZ, MPH, FCP SA Department of Medicine UZ-CHS
Blood Glucose Monitoring Liz Gregory / Sue Russell October 2013.
Glycemia Treatment Strategies Used In ACCORD
Copyright © 2015 by the American Osteopathic Association.
Copyright © 2017 American Academy of Pediatrics.
Copyright © 2006 American Medical Association. All rights reserved.
Type 1 Diabetes: Meters, Pumps, and Transitions to Adulthood
Short-, Intermediate-, Long-Acting Insulins
Diabetic Dyslipidemia in Practice
Engaging the INSULIN-TREATED T2DM Patient: the Importance of Real-World Data.
Deciphering Obesity Management Guidelines
Lifestyle and Professional CGM
Achieving Excellent Control of Hyperglycemia in Critical Care and Surgery, Safely: Continuous Glucose Monitoring: Does it Have a Future in the Hospital.
Special Consideration in Insulin Therapy
Using the AGP to Standardize Glucose Reporting
New Patient-Friendly Options for Managing Insulin Dosing
Modern Strategies for Basal Insulin Use in T2D
Diabetes Self-Management Education and Support: Component of Standard Diabetes Care 1, 2 “… Ongoing patient self-management education and support are.
Clinical Advances in Type 2 Diabetes and Cardiovascular Risk
Hemoglobin A1c Targets for Glycemic Controls
Best Practices in Advanced Glucose Monitoring
SGLT2 Inhibitors in the Modern Era: Why and Where?
Updates to Managing Diabetes in the Long-Term Care Setting
Goals. Achieving HbA1c Goals: Applying Guidelines to Intensify Therapy in Patients With Diabetes.
Talking to Patients About Diabetes Management
Athena Philis-Tsimikas, MD  The American Journal of Medicine 
Integrated Diabetes Care: How Can We Make the Best Use of New Technology?
Patients With T2D Presenting With Glycosuria: Examining the SGLT2 MOA
George Dailey, MD  Mayo Clinic Proceedings 
The Research Question Does self monitoring of blood glucose (SMBG) in patients with non-insulin treated type 2 diabetes improve glycemia or quality of.
New Horizons in Adjunctive Type 1 Diabetes Management With SGLT Inhibitors.
The Primary Care Guide to New CGM Devices and the AGP
Glucose Monitoring: An Evolving Landscape
Fig. 1. Glycemic variability in three hypothetical patients who have the same mean blood glucose concentration. Patient B has relatively small variations.
Better Diabetes Control With Novel Basal Insulins
Background. Advancing the Care of Patients With Moderate to Severe Atopic Dermatitis: A Case-Based Discussion.
Novel Insulin/GLP-1 Combinations: Of Interest to the Primary Care Physician?
When Is Intrathecal Drug Delivery Appropriate?
Optimizing Insulin Therapy in Primary Care: Basal Plus Incretin Combinations.
Younger Patients With Type 1 Diabetes: Can We Optimize Their Insulin Therapy?
Approach to starting and adjusting insulin in type 2 diabetes.
Oral Combination Therapy for T2D
Panelists. Cardiovascular Risk Modulation in Diabetes: Emerging Pathways and Insights.
Advancements in Glucose Monitoring
Hypoglycemia: The Most Common Barrier to Effective Diabetes Management
Communicating With Your Patients About Major Depressive Disorder
Patients With T2D Presenting With Glycosuria: Examining the SGLT2 MOA
Improving Adherence to Antiplatelet Therapy After an ACS Event
When Is Intrathecal Drug Delivery Appropriate?
Antibiotic De-Escalation
HF-Related Hospitalization and Readmissions
Part 2.
Type 1 Diabetes: Expanding Options for Adjunctive Oral Therapy With SGLT Inhibitors.
Statin Selection in Patients With Pre-Diabetes: Case Considerations
Patient flowchart of recruitment and treatment failure and success with glyburide vs. metformin. Patient flowchart of recruitment and treatment failure.
Representative study BG profiles from the forearm and the fingertip of six patients with diabetes. Representative study BG profiles from the forearm and.
Risk Stratification of Patients With Type 2 Diabetes: An Interpretation of the Latest Treatment Guidelines.
Fresh perspectives ON BASAL Insulins in diabetes care
ERRs (degludec/glargine U100) of hypoglycemia in Hispanic and non-Hispanic patients during the SWITCH 2 trial. ERRs (degludec/glargine U100) of hypoglycemia.
Benchmarking scatterplot for non-ICU units.
Presentation transcript:

Modern Advances in Glucose Monitoring

Program Goals

Why Is There a Need for the AGP?

How Data Drive Improvement

Using Data to Guide Clinical Decision-Making 14-Day Glucose Profiles

Using Data to Guide Clinical Decision-Making Glucose Patterns

Using Data to Guide Clinical Decision-Making Glucose Statistics

Patient Education The Ideal AGP

Patient Education An AGP With Ups and Downs

Share the Data With the Patient

AGP for Patients Monitoring Their Glucose Using SMBG

Use of AGP in Clinical Practice

Identifying Glycemic Trouble Spots Hypoglycemia and Hyperglycemia

Using AGP to Identify Adjustments in Therapy

How AGP Can Help Guide Safe Treatment Decisions

Diabetes Self-Management Education and Support Algorithm of Care

How AGP Can Help Patients

Abbreviations